Saba Capital Management Amends 13D Filing for New Germany Fund
Ticker: GF · Form: SC 13D/A · Filed: Oct 15, 2024 · CIK: 858706
Sentiment: neutral
Topics: 13D-filing, amendment, activist-investor
TL;DR
Saba Capital updated its 13D filing for New Germany Fund. Watch for potential strategy changes.
AI Summary
Saba Capital Management, L.P. filed an amendment (No. 1) to its Schedule 13D on October 15, 2024, regarding its holdings in The New Germany Fund, Inc. The filing indicates a change in the reporting person's beneficial ownership of the issuer's common shares. Saba Capital Management, L.P. is the filer, with Michael D'Angelo listed as the contact person.
Why It Matters
This amendment signals a potential shift in Saba Capital's stake or strategy concerning The New Germany Fund, which could influence the fund's future operations or stock performance.
Risk Assessment
Risk Level: medium — Amendments to 13D filings often precede significant corporate actions or shifts in investor strategy, which can introduce volatility.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Reporting Person
- The New Germany Fund, Inc. (company) — Issuer
- Michael D'Angelo (person) — Contact Person
- October 15, 2024 (date) — Filing Date
FAQ
What specific changes in beneficial ownership are detailed in this SC 13D/A filing?
The filing is an amendment (No. 1) to a Schedule 13D, indicating a change in the reporting person's beneficial ownership, but the exact percentage or number of shares is not detailed in the provided text.
Who is the primary filer for this amendment?
Saba Capital Management, L.P. is the primary filer for this SC 13D/A amendment.
What is the CUSIP number for The New Germany Fund, Inc. common shares?
The CUSIP number for The New Germany Fund, Inc. common shares is 644465106.
When was this amendment filed with the SEC?
This amendment was filed on October 15, 2024.
Who is the designated contact person for receiving notices and communications regarding this filing?
Michael D'Angelo, at Saba Capital Management, L.P., is the person authorized to receive notices and communications.
Filing Stats: 1,343 words · 5 min read · ~4 pages · Grade level 10.8 · Accepted 2024-10-15 18:30:50
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
- $8,861,568 — ported herein. A total of approximately $8,861,568 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 60KB
- 0001062993-24-017689.txt ( ) — 62KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 15, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 644465106 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D on 9/9/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 9/9/2024 Buy 208 8.39 9/13/2024 Buy 1,459 8.38 9/16/2024 Buy 500 8.40 9/17/2024 Buy 9,132 8.49 9/19/2024 Buy 1,850 8.65 9/19/2024 Buy 1,398 8.70 9/23/2024 Buy 4,045 8.59 9/25/2024 Buy 29,907 8.64 9/26/2024 Buy 6,850 8.88 9/27/2024 Buy 4,222 8.98 10/1/2024 Buy 15,580 8.89 10/4/2024 Buy 6,900 8.76 10/7/2024 Buy 22,846 8.69 10/9/2024 Buy 48,042 8.67 10/14/2024 Buy 67,963 8.70